-
1
-
-
67650999875
-
The basics of epithelial-mesenchymal transition
-
Kalluri R, Weinberg RA. The basics of epithelial-mesenchymal transition. J Clin Invest 2009;119:1420-8.
-
(2009)
J Clin Invest
, vol.119
, pp. 1420-1428
-
-
Kalluri, R.1
Weinberg, R.A.2
-
2
-
-
70450198396
-
Epithelial-mesenchymal transitions in development and disease
-
Thiery JP, Acloque H, Huang RY, Nieto MA. Epithelial-mesenchymal transitions in development and disease. Cell 2009;139:871-90.
-
(2009)
Cell
, vol.139
, pp. 871-890
-
-
Thiery, J.P.1
Acloque, H.2
Huang, R.Y.3
Nieto, M.A.4
-
3
-
-
84866325625
-
The epithelial-mesenchymal transition under control: Global programs to regulate epithelial plasticity
-
Nieto MA, Cano A. The epithelial-mesenchymal transition under control: global programs to regulate epithelial plasticity. Semin Cancer Biol 2012;22:361-8.
-
(2012)
Semin Cancer Biol
, vol.22
, pp. 361-368
-
-
Nieto, M.A.1
Cano, A.2
-
4
-
-
34250705693
-
β-Catenin and ZO-1: Shuttle molecules involved in tumor invasion-associated epithelial-mesenchymal transition processes
-
Polette M, Mestdagt M, Bindels S, Nawrocki-Raby B, Hunziker W, Foidart JM, et al. β-Catenin and ZO-1: shuttle molecules involved in tumor invasion-associated epithelial-mesenchymal transition processes. Cells Tissues Organs 2007;185:61-5.
-
(2007)
Cells Tissues Organs
, vol.185
, pp. 61-65
-
-
Polette, M.1
Mestdagt, M.2
Bindels, S.3
Nawrocki-Raby, B.4
Hunziker, W.5
Foidart, J.M.6
-
5
-
-
42749091317
-
Epithelial-mesenchymal transition and the invasive potential of tumors
-
Gavert N, Ben-Ze'ev A. Epithelial-mesenchymal transition and the invasive potential of tumors. Trends Mol Med 2008;14:199-209.
-
(2008)
Trends Mol Med
, vol.14
, pp. 199-209
-
-
Gavert, N.1
Ben-Ze'Ev, A.2
-
6
-
-
77954863256
-
Epithelial-to-mesenchymal transitions and circulating tumor cells
-
Bonnomet A, Brysse A, Tachsidis A, Waltham M, Thompson EW, Polette M, et al. Epithelial-to-mesenchymal transitions and circulating tumor cells. J Mammary Gland Biol Neoplasia 2010;15:261-73.
-
(2010)
J Mammary Gland Biol Neoplasia
, vol.15
, pp. 261-273
-
-
Bonnomet, A.1
Brysse, A.2
Tachsidis, A.3
Waltham, M.4
Thompson, E.W.5
Polette, M.6
-
7
-
-
42649137241
-
Mechanisms of disease: Epithelial-mesenchymal transition-does cellular plasticity fuel neoplastic progression?
-
Turley EA, Veiseh M, Radisky DC, Bissell MJ. Mechanisms of disease: epithelial-mesenchymal transition-does cellular plasticity fuel neoplastic progression? Nat Clin Pract Oncol 2008;5:280-90.
-
(2008)
Nat Clin Pract Oncol
, vol.5
, pp. 280-290
-
-
Turley, E.A.1
Veiseh, M.2
Radisky, D.C.3
Bissell, M.J.4
-
8
-
-
70449732503
-
Matrix metalloproteinases as novel biomarkers and potential therapeutic targets in human cancer
-
Roy R, Yang J, Moses MA. Matrix metalloproteinases as novel biomarkers and potential therapeutic targets in human cancer. J Clin Oncol 2009;27:5287-97.
-
(2009)
J Clin Oncol
, vol.27
, pp. 5287-5297
-
-
Roy, R.1
Yang, J.2
Moses, M.A.3
-
9
-
-
84867578091
-
EMT-activating transcription factors in cancer: Beyond EMT and tumor invasiveness
-
Sanchez-Tillo E, Liu Y, De BO, Siles L, Fanlo L, Cuatrecasas M, et al. EMT-activating transcription factors in cancer: beyond EMT and tumor invasiveness. Cell Mol Life Sci 2012;69:3429-56.
-
(2012)
Cell Mol Life Sci
, vol.69
, pp. 3429-3456
-
-
Sanchez-Tillo, E.1
Liu, Y.2
De, B.O.3
Siles, L.4
Fanlo, L.5
Cuatrecasas, M.6
-
10
-
-
84866652772
-
Emerging evidence of epithelial-tomesenchymal transition in lung carcinogenesis
-
Sato M, Shames DS, Hasegawa Y. Emerging evidence of epithelial- tomesenchymal transition in lung carcinogenesis. Respirology 2012;17: 1048-59.
-
(2012)
Respirology
, vol.17
, pp. 1048-1059
-
-
Sato, M.1
Shames, D.S.2
Hasegawa, Y.3
-
11
-
-
84879080694
-
Vimentin expression predicts the occurrence of metastases in non-small cell lung carcinomas
-
Dauphin M, Barbe C, Lemaire S, Nawrocki-Raby B, Lagonotte E, Delepine G, et al. Vimentin expression predicts the occurrence of metastases in non-small cell lung carcinomas. Lung Cancer 2013; 81:117-22.
-
(2013)
Lung Cancer
, vol.81
, pp. 117-122
-
-
Dauphin, M.1
Barbe, C.2
Lemaire, S.3
Nawrocki-Raby, B.4
Lagonotte, E.5
Delepine, G.6
-
12
-
-
29344465338
-
Epithelial versus mesenchymal phenotype determines in vitro sensitivity and predicts clinical activity of erlotinib in lung cancer patients
-
Yauch RL, Januario T, Eberhard DA, Cavet G, Zhu W, Fu L, et al. Epithelial versus mesenchymal phenotype determines in vitro sensitivity and predicts clinical activity of erlotinib in lung cancer patients. Clin Cancer Res 2005;11:8686-98.
-
(2005)
Clin Cancer Res
, vol.11
, pp. 8686-8698
-
-
Yauch, R.L.1
Januario, T.2
Eberhard, D.A.3
Cavet, G.4
Zhu, W.5
Fu, L.6
-
13
-
-
80052403945
-
The EMT regulator Slug and lung carcinogenesis
-
Shih JY, Yang PC. The EMT regulator Slug and lung carcinogenesis. Carcinogenesis 2011;32:1299-304.
-
(2011)
Carcinogenesis
, vol.32
, pp. 1299-1304
-
-
Shih, J.Y.1
Yang, P.C.2
-
14
-
-
13344279424
-
The FHIT gene, spanning the chromosome 3p14.2 fragile site and renal carcinoma-associated t(3;8) breakpoint, is abnormal in digestive tract cancers
-
Ohta M, Inoue H, Cotticelli MG, Kastury K, Baffa R, Palazzo J, et al. The FHIT gene, spanning the chromosome 3p14.2 fragile site and renal carcinoma-associated t(3;8) breakpoint, is abnormal in digestive tract cancers. Cell 1996;84:587-97.
-
(1996)
Cell
, vol.84
, pp. 587-597
-
-
Ohta, M.1
Inoue, H.2
Cotticelli, M.G.3
Kastury, K.4
Baffa, R.5
Palazzo, J.6
-
15
-
-
77950407493
-
Pathology and biology associated with the fragile FHIT gene and gene product
-
Saldivar JC, Shibata H, Huebner K. Pathology and biology associated with the fragile FHIT gene and gene product. J Cell Biochem 2010;109:858-65.
-
(2010)
J Cell Biochem
, vol.109
, pp. 858-865
-
-
Saldivar, J.C.1
Shibata, H.2
Huebner, K.3
-
16
-
-
13144262880
-
Replacement of Fhit in cancer cells suppresses tumorigenicity
-
Siprashvili Z, Sozzi G, Barnes LD, McCue P, Robinson AK, Eryomin V, et al. Replacement of Fhit in cancer cells suppresses tumorigenicity. Proc Natl Acad Sci U S A 1997;94:13771-6.
-
(1997)
Proc Natl Acad Sci U S A
, vol.94
, pp. 13771-13776
-
-
Siprashvili, Z.1
Sozzi, G.2
Barnes, L.D.3
McCue, P.4
Robinson, A.K.5
Eryomin, V.6
-
17
-
-
77955858320
-
FHIT: Doubts are clear now
-
Wali A. FHIT: doubts are clear now. Sci World J 2010;10:1142-51.
-
(2010)
Sci World J
, vol.10
, pp. 1142-1151
-
-
Wali, A.1
-
18
-
-
79954458878
-
Hits Fhits and Nits: Beyond enzymatic function
-
Huebner K, Saldivar JC, Sun J, Shibata H, Druck T. Hits, Fhits and Nits: beyond enzymatic function. Adv Enzyme Regul 2011;51:208-17.
-
(2011)
Adv Enzyme Regul
, vol.51
, pp. 208-217
-
-
Huebner, K.1
Saldivar, J.C.2
Sun, J.3
Shibata, H.4
Druck, T.5
-
19
-
-
77649182955
-
Fhit regulates invasion of lung tumor cells
-
Joannes A, Bonnomet A, Bindels S, Polette M, Gilles C, Burlet H, et al. Fhit regulates invasion of lung tumor cells.Oncogene 2010;29:1203-13.
-
(2010)
Oncogene
, vol.29
, pp. 1203-1213
-
-
Joannes, A.1
Bonnomet, A.2
Bindels, S.3
Polette, M.4
Gilles, C.5
Burlet, H.6
-
20
-
-
24744470324
-
Membrane-type 1 matrix metalloproteinase expression is regulated by zonula occludens-1 in human breast cancer cells
-
Polette M, Gilles C, Nawrocki-Raby B, Lohi J, Hunziker W, Foidart JM, et al. Membrane-type 1 matrix metalloproteinase expression is regulated by zonula occludens-1 in human breast cancer cells. Cancer Res 2005;65:7691-8.
-
(2005)
Cancer Res
, vol.65
, pp. 7691-7698
-
-
Polette, M.1
Gilles, C.2
Nawrocki-Raby, B.3
Lohi, J.4
Hunziker, W.5
Foidart, J.M.6
-
21
-
-
0037504665
-
Transactivation of vimentin by β-catenin in human breast cancer cells
-
Gilles C, Polette M, Mestdagt M, Nawrocki-Raby B, Ruggeri P, Birembaut P, et al. Transactivation of vimentin by β-catenin in human breast cancer cells. Cancer Res 2003;63:2658-64.
-
(2003)
Cancer Res
, vol.63
, pp. 2658-2664
-
-
Gilles, C.1
Polette, M.2
Mestdagt, M.3
Nawrocki-Raby, B.4
Ruggeri, P.5
Birembaut, P.6
-
22
-
-
34249289041
-
Snail, Zeb and bHLH factors in tumour progression: An alliance against the epithelial phenotype?
-
Peinado H, Olmeda D, Cano A. Snail, Zeb and bHLH factors in tumour progression: an alliance against the epithelial phenotype? Nat Rev Cancer 2007;7:415-28.
-
(2007)
Nat Rev Cancer
, vol.7
, pp. 415-428
-
-
Peinado, H.1
Olmeda, D.2
Cano, A.3
-
24
-
-
79952075985
-
Slug enhances invasion ability of pancreatic cancer cells through upregulation of matrix metalloproteinase-9 and actin cytoskeleton remodeling
-
Zhang K, Chen D, Jiao X, Zhang S, Liu X, Cao J, et al. Slug enhances invasion ability of pancreatic cancer cells through upregulation of matrix metalloproteinase-9 and actin cytoskeleton remodeling. Lab Invest 2011;91:426-38.
-
(2011)
Lab Invest
, vol.91
, pp. 426-438
-
-
Zhang, K.1
Chen, D.2
Jiao, X.3
Zhang, S.4
Liu, X.5
Cao, J.6
-
25
-
-
70350143237
-
Slug is a downstream mediator of transforming growth factor-β1- induced matrix metalloproteinase-9 expression and invasion of oral cancer cells
-
Joseph MJ, Dangi-Garimella S, Shields MA, Diamond ME, Sun L, Koblinski JE, et al. Slug is a downstream mediator of transforming growth factor-β1-induced matrix metalloproteinase-9 expression and invasion of oral cancer cells. J Cell Biochem 2009;108:726-36.
-
(2009)
J Cell Biochem
, vol.108
, pp. 726-736
-
-
Joseph, M.J.1
Dangi-Garimella, S.2
Shields, M.A.3
Diamond, M.E.4
Sun, L.5
Koblinski, J.E.6
-
26
-
-
79953060389
-
Vimentin regulates EMT induction by Slug and oncogenic H-Ras and migration by governing Axl expression in breast cancer
-
Vuoriluoto K, Haugen H, Kiviluoto S, Mpindi JP, Nevo J, Gjerdrum C, et al. Vimentin regulates EMT induction by Slug and oncogenic H-Ras and migration by governing Axl expression in breast cancer. Oncogene 2011;30:1436-48.
-
(2011)
Oncogene
, vol.30
, pp. 1436-1448
-
-
Vuoriluoto, K.1
Haugen, H.2
Kiviluoto, S.3
Mpindi, J.P.4
Nevo, J.5
Gjerdrum, C.6
-
27
-
-
78149302129
-
Integrated proteomics and genomics analysis reveals a novel mesenchymal to epithelial reverting transition in leiomyosarcoma through regulation of Slug
-
Yang J, Eddy JA, Pan Y, Hategan A, Tabus I, Wang Y, et al. Integrated proteomics and genomics analysis reveals a novel mesenchymal to epithelial reverting transition in leiomyosarcoma through regulation of Slug. Mol Cell Proteomics 2010;9:2405-13.
-
(2010)
Mol Cell Proteomics
, vol.9
, pp. 2405-2413
-
-
Yang, J.1
Eddy, J.A.2
Pan, Y.3
Hategan, A.4
Tabus, I.5
Wang, Y.6
-
28
-
-
58149288656
-
Erk5 controls Slug expression and keratinocyte activation during wound healing
-
Arnoux V, Nassour M, L'Helgoualc'h A, Hipskind RA, Savagner P. Erk5 controls Slug expression and keratinocyte activation during wound healing. Mol Biol Cell 2008;19:4738-49.
-
(2008)
Mol Biol Cell
, vol.19
, pp. 4738-4749
-
-
Arnoux, V.1
Nassour, M.2
L'Helgoualc'H, A.3
Hipskind, R.A.4
Savagner, P.5
-
29
-
-
0345599013
-
Autoregulation of E-cadherin expression by cadherincadherin interactions: The roles of β-catenin signaling, Slug, and MAPK
-
Conacci-Sorrell M, Simcha I, Ben-Yedidia T, Blechman J, Savagner P, Ben-Ze'ev A. Autoregulation of E-cadherin expression by cadherincadherin interactions: the roles of β-catenin signaling, Slug, and MAPK. J Cell Biol 2003;163:847-57.
-
(2003)
J Cell Biol
, vol.163
, pp. 847-857
-
-
Conacci-Sorrell, M.1
Simcha, I.2
Ben-Yedidia, T.3
Blechman, J.4
Savagner, P.5
Ben-Ze'Ev, A.6
-
30
-
-
73649124286
-
Extracellular signal-regulated kinase signaling pathway regulates breast cancer cell migration by maintaining Slug expression
-
Chen H, Zhu G, Li Y, Padia RN, Dong Z, Pan ZK, et al. Extracellular signal-regulated kinase signaling pathway regulates breast cancer cell migration by maintaining Slug expression. Cancer Res 2009;69: 9228-35.
-
(2009)
Cancer Res
, vol.69
, pp. 9228-9235
-
-
Chen, H.1
Zhu, G.2
Li, Y.3
Padia, R.N.4
Dong, Z.5
Pan, Z.K.6
-
31
-
-
60549108144
-
Clusterin silencing in human lung adenocarcinoma cells induces a mesenchymal-to-epithelial transition through modulating the ERK/Slug pathway
-
Chou TY, Chen WC, Lee AC, Hung SM, Shih NY, Chen MY. Clusterin silencing in human lung adenocarcinoma cells induces a mesenchymal-to-epithelial transition through modulating the ERK/Slug pathway. Cell Signal 2009;21:704-11.
-
(2009)
Cell Signal
, vol.21
, pp. 704-711
-
-
Chou, T.Y.1
Chen, W.C.2
Lee, A.C.3
Hung, S.M.4
Shih, N.Y.5
Chen, M.Y.6
-
32
-
-
84855224166
-
C-Src-mediated RANKL-induced breast cancer cell migration by activation of the ERK and Akt pathway
-
Zhang L, Teng Y, Zhang Y, Liu J, Xu L, Qu J, et al. C-Src-mediated RANKL-induced breast cancer cell migration by activation of the ERK and Akt pathway. Oncol Lett 2012;3:395-400.
-
(2012)
Oncol Lett
, vol.3
, pp. 395-400
-
-
Zhang, L.1
Teng, Y.2
Zhang, Y.3
Liu, J.4
Xu, L.5
Qu, J.6
-
33
-
-
56049123161
-
Proline-rich tyrosine kinase 2 (Pyk2) promotes proliferation and invasiveness of hepatocellular carcinoma cells through c-Src/ERK activation
-
Sun CK, Man K, Ng KT, Ho JW, Lim ZX, Cheng Q, et al. Proline-rich tyrosine kinase 2 (Pyk2) promotes proliferation and invasiveness of hepatocellular carcinoma cells through c-Src/ERK activation. Carcinogenesis 2008;29:2096-105.
-
(2008)
Carcinogenesis
, vol.29
, pp. 2096-2105
-
-
Sun, C.K.1
Man, K.2
Ng, K.T.3
Ho, J.W.4
Lim, Z.X.5
Cheng, Q.6
-
34
-
-
84871961245
-
Combination of MEK and SRC inhibition suppresses melanoma cell growth and invasion
-
Ferguson J, Arozarena I, Ehrhardt M, Wellbrock C. Combination of MEK and SRC inhibition suppresses melanoma cell growth and invasion. Oncogene 2013;32:86-96.
-
(2013)
Oncogene
, vol.32
, pp. 86-96
-
-
Ferguson, J.1
Arozarena, I.2
Ehrhardt, M.3
Wellbrock, C.4
-
35
-
-
75749103348
-
Src signaling in cancer invasion
-
Guarino M. Src signaling in cancer invasion. J Cell Physiol 2010;223: 14-26.
-
(2010)
J Cell Physiol
, vol.223
, pp. 14-26
-
-
Guarino, M.1
-
36
-
-
67650588774
-
Characterisation of fibronectin-mediated FAK signalling pathways in lung cancer cell migration and invasion
-
Meng XN, Jin Y, Yu Y, Bai J, Liu GY, Zhu J, et al. Characterisation of fibronectin-mediated FAK signalling pathways in lung cancer cell migration and invasion. Br J Cancer 2009;101:327-34.
-
(2009)
Br J Cancer
, vol.101
, pp. 327-334
-
-
Meng, X.N.1
Jin, Y.2
Yu, Y.3
Bai, J.4
Liu, G.Y.5
Zhu, J.6
-
37
-
-
85047696594
-
Src kinase contributes to the metastatic spread of carcinoma cells
-
Boyer B, Bourgeois Y, Poupon MF. Src kinase contributes to the metastatic spread of carcinoma cells. Oncogene 2002;21:2347-56.
-
(2002)
Oncogene
, vol.21
, pp. 2347-2356
-
-
Boyer, B.1
Bourgeois, Y.2
Poupon, M.F.3
-
38
-
-
40549085666
-
Overexpression of vimentin contributes to prostate cancer invasion and metastasis via src regulation
-
Wei J, Xu G, Wu M, Zhang Y, Li Q, Liu P, et al. Overexpression of vimentin contributes to prostate cancer invasion and metastasis via src regulation. Anticancer Res 2008;28:327-34.
-
(2008)
Anticancer Res
, vol.28
, pp. 327-334
-
-
Wei, J.1
Xu, G.2
Wu, M.3
Zhang, Y.4
Li, Q.5
Liu, P.6
-
39
-
-
47549092230
-
Bypassing cellular EGF receptor dependence through epithelialto- mesenchymal-like transitions
-
Barr S, Thomson S, Buck E, Russo S, Petti F, Sujka-Kwok I, et al. Bypassing cellular EGF receptor dependence through epithelialto-mesenchymal-like transitions. Clin Exp Metastasis 2008;25: 685-93.
-
(2008)
Clin Exp Metastasis
, vol.25
, pp. 685-693
-
-
Barr, S.1
Thomson, S.2
Buck, E.3
Russo, S.4
Petti, F.5
Sujka-Kwok, I.6
-
40
-
-
34249979835
-
Epidermal growth factor and transforming growth factor-b1 enhance HK-2 cell migration through a synergistic increase of matrix metalloproteinase and sustained activation of ERK signaling pathway
-
Tian YC, Chen YC, Chang CT, Hung CC, Wu MS, Phillips A, et al. Epidermal growth factor and transforming growth factor-b1 enhance HK-2 cell migration through a synergistic increase of matrix metalloproteinase and sustained activation of ERK signaling pathway. Exp Cell Res 2007;313:2367-77.
-
(2007)
Exp Cell Res
, vol.313
, pp. 2367-2377
-
-
Tian, Y.C.1
Chen, Y.C.2
Chang, C.T.3
Hung, C.C.4
Wu, M.S.5
Phillips, A.6
-
41
-
-
84860389234
-
Activation of EGFR promotes squamous carcinoma SCC10A cell migration and invasion via inducing EMT-like phenotype change and MMP-9-mediated degradation of E-cadherin
-
Zuo JH, Zhu W, Li MY, Li XH, Yi H, Zeng GQ, et al. Activation of EGFR promotes squamous carcinoma SCC10A cell migration and invasion via inducing EMT-like phenotype change and MMP-9-mediated degradation of E-cadherin. J Cell Biochem 2011;112:2508-17.
-
(2011)
J Cell Biochem
, vol.112
, pp. 2508-2517
-
-
Zuo, J.H.1
Zhu, W.2
Li, M.Y.3
Li, X.H.4
Yi, H.5
Zeng, G.Q.6
-
42
-
-
34047197438
-
FHIT-proteasome degradation caused by mitogenic stimulation of the EGF receptor family in cancer cells
-
Bianchi F, Magnifico A, Olgiati C, Zanesi N, Pekarsky Y, Tagliabue E, et al. FHIT-proteasome degradation caused by mitogenic stimulation of the EGF receptor family in cancer cells. Proc Natl Acad Sci U S A 2006;103:18981-6.
-
(2006)
Proc Natl Acad Sci U S A
, vol.103
, pp. 18981-18986
-
-
Bianchi, F.1
Magnifico, A.2
Olgiati, C.3
Zanesi, N.4
Pekarsky, Y.5
Tagliabue, E.6
-
43
-
-
44649115694
-
Targeting epidermal growth factor receptor and SRC pathways in head and neck cancer
-
Egloff AM, Grandis JR. Targeting epidermal growth factor receptor and SRC pathways in head and neck cancer. Semin Oncol. 2008;35: 286-97.
-
(2008)
Semin Oncol.
, vol.35
, pp. 286-297
-
-
Egloff, A.M.1
Grandis, J.R.2
-
44
-
-
1642329754
-
Fhit is a physiological target of the protein kinase Src
-
Pekarsky Y, Garrison PN, Palamarchuk A, Zanesi N, Aqeilan RI, Huebner K, et al. Fhit is a physiological target of the protein kinase Src. Proc Natl Acad Sci U S A 2004;101:3775-9.
-
(2004)
Proc Natl Acad Sci U S A
, vol.101
, pp. 3775-3779
-
-
Pekarsky, Y.1
Garrison, P.N.2
Palamarchuk, A.3
Zanesi, N.4
Aqeilan, R.I.5
Huebner, K.6
|